HOME > ARCHIVE
ARCHIVE
- Fukujin Aims at Group Sales of \1 Trillion in 2006
March 17, 2003
- OUA 3rd Academic Meeting Held
March 17, 2003
- Toho Determined to Reach Price Accord by End of March
March 17, 2003
- Deregulation WG Clashes with Korosho in OTC Sale
March 17, 2003
- OPMA to Reorganize Its Structure
March 17, 2003
- AJD to Expand Activities of Home Medication Kyokai
March 17, 2003
- BUSINESS NEWS IN BRIEF
March 10, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
March 10, 2003
- WEBSITE NEWS
March 10, 2003
- Fujisawa Updates R&D Pipeline
March 10, 2003
- CORPORATE ROUNDUP NEWS IN BRIEF
March 10, 2003
- PRESS SEMINAR
March 10, 2003
- Gov't Allows Private Companies to Operate Medical Institutions
March 10, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
March 10, 2003
- Schedule for Changes in Approval Procedures Outlined
March 10, 2003
- Toyama Transfers OTC Products to Taisho, Kyorin
March 10, 2003
- PFSB Taking Public Comments on Amended PAL Ordinances
March 10, 2003
- JACDS Drafting GLs for Introduction of Category Management
March 10, 2003
- JMA to Stress Need for Higher Price Adjustment Zone
March 10, 2003
- OTC NEWS IN BRIEF
March 10, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
